Clinical-stage biotechnology company pursuing the development of novel small molecules that target cancer through its dependency on stress support pathways.
- Ellie Diagnostics Raises Growth Equity from Avego Healthcare Capital
- Antios Therapeutics Raises $75 Million in a Series B-1 Funding to Advance Clinical Programs for HBV
- Jasper Therapeutics Closes Transaction With Amplitude Healthcare Acquisition Corporation
- Ribon Therapeutics Secures $65 Million Financing
- Jasper Therapeutics and Amplitude Healthcare Acquisition Corporation Announce Merger to Create a Publicly Listed Leading Biotechnology Company in Hematopoietic Stem Cell Transplantation
- Arch Oncology Secures $105 Million Series C Financing